⌕
MoonLake Immunotherapeutics · MLTX · Nasdaq
Tenet 51 · Mixed
Compare
$11.73−6.16%At closeTenet 51 · Mixed
$11.73−0.77 (−6.16%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

MoonLake Immunotherapeutics (MLTX) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is MLTX's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● GlobeNewsWireNov 4, 2026 · 07:00 ETCOMPANY'S OWN WORDS
MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update

ZUG, Switzerland, November 4, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, to…

MLTX −6.2% todayRead at source ↗
● BenzingaOct 22, 2026 · 14:23 ET
What's Going On with MoonLake Immunotherapeutics Stock on Thursday?

MoonLake Immunotherapeutics (NASDAQ:MLTX) stock is trading higher on Thursday with a session volume of 4.20 million compared to the average volume of 1.494 million, according to Benzinga Pro data.…

MLTX −6.2% todayRead at source ↗
● Seeking AlphaSep 8, 2026 · 10:35 ET
MoonLake Immunotherapeutics: The Bull Case Does Not Require Clinical Supremacy

MoonLake Immunotherapeutics offers a compelling investment case despite sonelokimab's mixed clinical results, focusing on regulatory progress and commercial viability. MLTX can file for HS approval without another major …

MLTX −6.2% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

Article counts from the last market-wide feed page, across every symbol we track and not just MLTX · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.